← Back
Data updated: Mar 10, 2026
YUNG SHIN PHARM
Infectious DiseaseDermatologyGastroenterology
YUNG SHIN PHARM is a generic drug manufacturer focused on Infectious Disease, Dermatology, Gastroenterology. Key products include ZOLPIDEM TARTRATE.
2004
Since
11
Drugs
-
Trials
70
Approved (2yr)
Recent Activity
AZITHROMYCIN 2025-09-23
Labeling
ELETRIPTAN HYDROBROMIDE 2025-07-07
CEPHALEXIN 2025-05-07
Labeling
CEPHALEXIN 2025-05-07
Labeling
CEPHALEXIN 2025-05-07
Labeling
CEPHALEXIN 2025-05-07
Labeling
DICLOFENAC SODIUM AND MISOPROSTOL 2025-03-31
Labeling
DICLOFENAC SODIUM AND MISOPROSTOL 2025-03-31
Labeling
DICLOFENAC SODIUM AND MISOPROSTOL 2025-03-31
Labeling
DICLOFENAC SODIUM AND MISOPROSTOL 2025-03-31
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 27%
2 drugs Phase 1: 2
Dermatology 24%
2 drugs
Gastroenterology 24%
2 drugs
Neurology 14%
1 drugs Phase 1: 1
Immunology 12%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Infectious Disease, Neurology
AbbVie big-pharma
Immunology, Neurology, Infectious Disease
PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Immunology
GSK big-pharma
Infectious Disease, Immunology, Neurology
Active (6)
Discontinued (5)
Company Info
- First Approval
- 2004-01-22
- Latest
- 2024-12-23
- Applications
- 14